FI922343A - Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI922343A FI922343A FI922343A FI922343A FI922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A FI 922343 A FI922343 A FI 922343A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- independently
- therapeutically useful
- pyrrolidine derivatives
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909000304A GB9000304D0 (en) | 1990-01-06 | 1990-01-06 | Muscarinic receptor antagonists |
| GB9000304 | 1990-01-06 | ||
| PCT/EP1990/002041 WO1991010647A1 (en) | 1990-01-06 | 1990-11-28 | Muscarinic receptor antagonists |
| EP9002041 | 1990-11-28 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI922343A true FI922343A (fi) | 1992-05-22 |
| FI922343A0 FI922343A0 (fi) | 1992-05-22 |
| FI95026B FI95026B (fi) | 1995-08-31 |
| FI95026C FI95026C (fi) | 1995-12-11 |
Family
ID=10668925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI922343A FI95026C (fi) | 1990-01-06 | 1992-05-22 | Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0508988B1 (fi) |
| JP (1) | JPH0657693B2 (fi) |
| AT (1) | ATE102183T1 (fi) |
| DE (1) | DE69007126T2 (fi) |
| DK (1) | DK0508988T3 (fi) |
| ES (1) | ES2063381T3 (fi) |
| FI (1) | FI95026C (fi) |
| GB (1) | GB9000304D0 (fi) |
| IE (1) | IE63691B1 (fi) |
| PT (1) | PT96419B (fi) |
| WO (1) | WO1991010647A1 (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2093798C (en) * | 1990-10-10 | 2000-02-01 | John J. Piwinski | Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof |
| EP0635012B1 (en) * | 1992-03-27 | 1996-07-10 | Schering Corporation | Unbridged bis-aryl carbinol derivatives, compositions and methods of use |
| ES2103675B1 (es) * | 1995-01-10 | 1998-07-01 | Almirall Lab | Nuevas piperidinas sustituidas. |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| WO1998047901A1 (en) * | 1997-04-18 | 1998-10-29 | Takeda Chemical Industries, Ltd. | Process for producing tricyclic compounds and their intermediates |
| WO2004089892A2 (en) * | 2003-04-01 | 2004-10-21 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| WO2005007645A1 (en) * | 2003-07-11 | 2005-01-27 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
| CN1893948A (zh) * | 2003-10-14 | 2007-01-10 | 葛兰素集团有限公司 | 蕈毒碱性乙酰胆碱受体拮抗剂 |
| PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
| US7250414B2 (en) * | 2004-03-11 | 2007-07-31 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| EP1725525A1 (en) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL76583A (en) * | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
| EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
-
1990
- 1990-01-06 GB GB909000304A patent/GB9000304D0/en active Pending
- 1990-11-28 AT AT90917100T patent/ATE102183T1/de not_active IP Right Cessation
- 1990-11-28 WO PCT/EP1990/002041 patent/WO1991010647A1/en active IP Right Grant
- 1990-11-28 DK DK90917100.1T patent/DK0508988T3/da active
- 1990-11-28 EP EP90917100A patent/EP0508988B1/en not_active Expired - Lifetime
- 1990-11-28 ES ES90917100T patent/ES2063381T3/es not_active Expired - Lifetime
- 1990-11-28 DE DE69007126T patent/DE69007126T2/de not_active Expired - Fee Related
- 1990-11-28 JP JP2515784A patent/JPH0657693B2/ja not_active Expired - Fee Related
-
1991
- 1991-01-04 PT PT96419A patent/PT96419B/pt not_active IP Right Cessation
- 1991-01-04 IE IE1991A patent/IE63691B1/en not_active IP Right Cessation
-
1992
- 1992-05-22 FI FI922343A patent/FI95026C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007126D1 (de) | 1994-04-07 |
| JPH05501554A (ja) | 1993-03-25 |
| ATE102183T1 (de) | 1994-03-15 |
| WO1991010647A1 (en) | 1991-07-25 |
| JPH0657693B2 (ja) | 1994-08-03 |
| GB9000304D0 (en) | 1990-03-07 |
| IE63691B1 (en) | 1995-05-31 |
| FI95026C (fi) | 1995-12-11 |
| FI95026B (fi) | 1995-08-31 |
| IE910019A1 (en) | 1991-07-17 |
| DK0508988T3 (da) | 1994-05-09 |
| EP0508988B1 (en) | 1994-03-02 |
| PT96419A (pt) | 1991-10-15 |
| EP0508988A1 (en) | 1992-10-21 |
| FI922343A0 (fi) | 1992-05-22 |
| ES2063381T3 (es) | 1995-01-01 |
| DE69007126T2 (de) | 1994-06-01 |
| PT96419B (pt) | 1998-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2067817A1 (en) | Muscarinic receptor antagonists | |
| US5096890B1 (en) | Pyrrolidine derivatives | |
| FI922345A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-substituoitujen pyrrolidiinijohdannaisten valmistamiseksi | |
| FI922343A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi | |
| FI97468B (fi) | Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi | |
| FI922346A0 (fi) | Muscarinreceptorantagonister. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application |